Personalized cancer vaccines target tumor-specific neoantigens, potentially improving immune system accuracy in attacking tumors. Zusduri shows promise in treating low-grade, intermediate-risk bladder ...

(WSET) — Sinclair Cares is partnering with the American Cancer Society to help drive out cancer. There are multiple resources and programs that help cancer patients. Every person touched by cancer is ...

“Winning the war on cancer” (July 19th) was a welcome and thoughtful overview, highlighting the tangible benefits of cancer prevention and even daring to address the frontier science of personalised ...

Lynozyfic received FDA accelerated approval for relapsed/refractory multiple myeloma, showing a 70% response rate in trials, but carries a boxed warning for severe side effects. CAR T-cell therapy is ...